5
Jun 26
Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma
Approval expands PD-L1 testing onto an automated workflow to support treatment decisions with KEYTRUDA® (pembrolizumab)¹,² SANTA CLARA, Calif., June 02,...
Read More
26
Mar 26
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma
Test enables identification of patients whose tumors express PD-L1 for potential treatment with KEYTRUDA® (pembrolizumab)1, 2 SANTA CLARA, Calif., March...
Read More
9
Mar 26
Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions
Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions SANTA CLARA, Calif, and SAN FRANCISCO,...
Read More
10
Mar 25
Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications
Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and...
Read More
4
Feb 25
World Cancer Day 2025 How Agilent is Driving Advanced Cancer Diagnostics
How Agilent is Driving Advanced Cancer Diagnostics For a quarter of a century, World Cancer Day (February 4th) has driven...
Read More
10
Dec 24
Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification
Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification SANTA CLARA, Calif., December 10, 2024 Agilent Technologies...
Read More
14
Nov 23
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Patients with gastric or...
Read More
24
Aug 23
Agilent Receives European IVDR Certification for Companion Diagnostic Assay
Agilent Receives European IVDR Certification for Companion Diagnostic Assay Agilent Technologies Inc. (NYSE: A) today announced the issuing of a...
Read More
7
Aug 23
Agilent Inaugurates First Integrated Biology Center at Monash University in Malaysia
Agilent Inaugurates First Integrated Biology Center at Monash University in Malaysia Agilent Technologies Inc. (NYSE: A) today announced the opening...
Read More
10
Jul 23
Agilent Announces Gen6 Software for BioTek Line of Microplate Readers
Agilent Announces Gen6 Software for BioTek Line of Microplate Readers Agilent Technologies Inc. (NYSE: A) today announced the launch of...
Read More
